Endothelial progenitor cell response to antiproliferative drug exposure

► Anti-proliferative drugs in FDA-approved drug-eluting stents inhibit endothelial progenitor cells. ► 1st generation drug-eluting stent (DES) drugs inhibit EPC proliferation. ► 2nd generation DES drugs are associated with lower EPC prothrombotic gene expression.